Macquarie Group
GBT

Macquarie Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Macquarie Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,527
Closed -$225K – 2252
2022
Q3 		$225K Sell
2,527
-771
-23% -$42.5K ﹤0.01% 1610
2022
Q2 		$105K Hold
3,298
– – ﹤0.01% 1867
2022
Q1 		$114 Hold
3,298
– – ﹤0.01% 1921
2021
Q4 		$97K Sell
3,298
-113
-3% -$3.5K ﹤0.01% 1949
2021
Q3 		$87K Buy
3,411
+1,949
+133% +$57.3K ﹤0.01% 2031
2021
Q2 		$51K Sell
1,462
-201
-12% -$7.85K ﹤0.01% 2158
2021
Q1 		$68K Sell
1,663
-515
-24% -$23.7K ﹤0.01% 2004
2020
Q4 		$94K Sell
2,178
-25,353
-92% -$1.25M ﹤0.01% 1891
2020
Q3 		$1.52M Buy
27,531
+1,075
+4% +$68.3K ﹤0.01% 1125
2020
Q2 		$1.67M Buy
26,456
+2,731
+12% +$187K ﹤0.01% 1063
2020
Q1 		$1.21M Buy
23,725
+22,125
+1,383% +$1.48M ﹤0.01% 1041
2019
Q4 		$127K Buy
+1,600
New +$94.8K ﹤0.01% 1727
2018
Q2 		– Sell
-25,737
Closed -$1.24M – 2309
2018
Q1 		$1.24M Buy
25,737
+25,437
+8,479% +$1.42M ﹤0.01% 1116
2017
Q4 		$12K Buy
+300
New +$11.2K ﹤0.01% 2246

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Macquarie Group's GBT Position: Q4 2022 in Review

Macquarie Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 2,527 shares — an estimated $225K sold.

Macquarie Group first reported a position in GBT in Q4 2017 and held it in 14 quarters. The position peaked at $1.67M in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Macquarie Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 2,527 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $225K.
  • Macquarie Group first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 14 quarters.
  • Macquarie Group's Global Blood Therapeutics, Inc. position peaked at $1.67M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.